01 · Ingest
Every paper, every day
PubMed, ClinicalTrials.gov, Cochrane. Indexed within hours of publication.
02 · Extract
Findings, not abstracts
Effect sizes, doses, cohorts, endpoints — pulled into a structured evidence graph.
03 · Personalize
Against your biology
Cross-referenced to your demographics, bloodwork, wearables, stack and goals.
04 · Act
What changes today
You get the specific recommendation and the specific study behind it. Every claim traceable.
Start with what matters to you. We'll match it to the evidence.
Pick a goal. Aviado assembles a starter stack from the ingredients with the strongest population-level evidence for people like you — then sharpens as you add more about your biology over time.
Your stack gets sharper the more you share.
Every Aviado user starts with goals. Precision deepens at your pace — there's no minimum data required.
- 01Goals + demographicsYou are here
Evidence scoped to your cohort — age, sex, diet, life stage. Today.
- 02+ WearablesWeek 1
Apple Watch, Oura, Whoop, CGM. Sleep, HRV, glucose, activity re-rank your stack in real time.
- 03+ Body compositionMonth 1
DEXA, InBody, or height/weight. Unlocks BMI-stratified evidence — like VITAL below.
- 04+ BloodworkMonth 3+
25-OH-D, Omega-3 index, ApoB, hs-CRP, ferritin. Biomarker-matched evidence — the full resolution.
The same pill cuts the odds of metastatic cancer by 38% — for some. For others, zero effect.
Vitamin D₃ didn't stop people from getting cancer. It stopped the cancer from turning metastatic — but only at normal BMI.
25,871 adults, 5 years, randomized. Initial cancer diagnoses were identical between vitamin D and placebo. The difference showed up later: among those who did develop cancer, vitamin D cut the chance it progressed to metastatic or fatal disease — by 17% overall, 38% in participants with BMI under 25. Among overweight or obese participants: no measurable effect. This is exactly the detail generic supplementation erases.
Aviado surfaces it — scoped to your biology.
Chandler et al · JAMA Network Open · 2020 · n=25,871 · PMID 33206192
Hundreds of supplement ingredients. 75,000+ products, scored.
Aviado's ProofMark grades branded supplements (Thorne, Pure Encapsulations, Nordic Naturals, the next-day Amazon brand you've never heard of) on testing, transparency, manufacturing and brand quality: over 75,000 products and counting. The evidence for each of hundreds of supplement ingredients is rated separately against the research. One standard for every bottle we catalog.
Our daily longevity & healthspan digest.
Friday, November 20, 2026
" A separate trial of a daily cortisol-blocking pill is showing 30% slower disease progression, suggesting multiple pathways to slowing dementia are now in play.
Read today's full issue →A new issue every morning — research signal, not product noise.
Today's edition
▶ Audio · ~4 minFriday, November 20, 2026
10 stories · 1 peer-reviewed · 2 trials
Twice-Yearly Alzheimer's Injection Cuts Cognitive Decline by 54% in Major Trial
The Independent
Daily Cortisol-Blocking Pill Slows Alzheimer's Progression by 30%, Trial Shows
Sydney Morning Herald
The Gut-Derived Compound in Pomegranates That May Protect Against Alzheimer's
mindbodygreen
Stop guessing. Start applying evidence.
Aviado is free to try. No credit card, we will build you a stack or import your exact protocol. BYOB (bring your own bloodwork) — or don't. Either way, today's research will find you.
Hope is not a strategy. It doesn't have to be.

